Skip to main content
. 2023 Apr 19;77(4):649–656. doi: 10.1093/cid/ciad239

Figure 4.

Figure 4.

Forest plot of the desirability of outcome ranking (DOOR) probabilities for the DOOR endpoint and each DOOR component. Trial A has no significant differences between the treatment arms in the component analysis (A). The study treatment arm was shown to be nominally statistically inferior for serious adverse events in trial B (B). Abbreviations: CI, confidence interval; DOOR, desirability of outcome ranking; ICs, infectious complications; SAEs, serious adverse events.